CVS Health Corporation (CVS)

90.87
0.88 0.98
NYSE
Prev Close 89.99
Open 90.64
Day Low/High 90.11 / 91.59
52 Wk Low/High 67.06 / 96.57
Volume 5.66M
Exchange NYSE
Shares Outstanding 1320.06B
Market Cap 117.19B
P/E Ratio 12.25
Div & Yield N.A. (N.A)
Taking Aim at 3 Healthcare Charts

Taking Aim at 3 Healthcare Charts

Where are Celgene, Isis and CVS heading?

The 7 Pillars of Healthcare Strength

The 7 Pillars of Healthcare Strength

Here are healthcare stocks of all shares and sizes with strong charts.

Cramer: Stay With the Winning Horse

When they aren't winning, they're hard to turn around.

CVS, Darden Charts Have Much in Common

CVS, Darden Charts Have Much in Common

A pair of strong charts with solid setups and recent history on their side.

Barclays Healthcare Conf.

Cramer: Total Eclipse of a Bearish Sun

A lot of stocks are doing incredibly well. 

Which Stocks Are in Style?

Cybersecurity, retail among the most fashionable.

Violent Moves in a 'Scarface' Market

The 'dead bodies' are adding up.

CVS upgraded at Goldman

Cramer: The 2 Who Forecast Netflix

Two analysts predicted the big rise in Netflix. Well done.

Getting Retail Right, Part 2

Getting Retail Right, Part 2

These store-based U.S. retailers are an eclectic mix.

Why I'm Sticking With Biotech

Why I'm Sticking With Biotech

They offer a nice shelter for the headwinds now hitting equities.

Gilead Is a Buying Opportunity

Gilead Is a Buying Opportunity

Its hepatitis C drug is better; the stock trades at a discount.

Stocks You Just Can't Ignore

And stop chasing stocks that won't let you in.

Go With What's Worked, Part 2

Let's look at the other groups that caught fire.

Don't Pay More Than MSRP for CVS

Don't Pay More Than MSRP for CVS

CVS is a healthy company trading at an unhealthy level.

The Daily Dose: More to Watch for From the Fed

Do your homework before the meeting.

CVS price target raised at Barclays

CVS Health numbers raised at JP Morgan

Cramer: Six Quick Rays of Light

We shouldn't expect lasting blows coming from oil's decline.

Goldilocks vs. the 3 Bears

Goldie like low oil, the bears like it high.

CVS Analyst Mtg.

CVS Health rated new Neutral at Citi

The Daily Dose: A Tale of Two Retailers

Sears is dying while Starbucks is thriving.

Cramer: A Dozen Sectors to Snap Up

As 2014 winds down, you could almost throw darts at these standout groups -- but here are my own picks.

The Daily Dose: Key Retail Trends

Aging consumers and longer winters change the landscape.

Cramer: Apple Is a Win for Walgreen

Cramer: Apple Is a Win for Walgreen

Adopting Apple's payment system is a smart move.

Jim Cramer: Rite Aid and CVS Won't Play Ball With Apple Pay

Jim Cramer: Rite Aid and CVS Won't Play Ball With Apple Pay

TheStreet's Jim Cramer shares his thoughts on drug retailers Rite Aid and CVS refusing to accept Apple Pay at their stores.

Five Things to Know Now: Stress Tests and Apple

Stress test results in Europe did not reveal major shortfalls.

Think Globally, Buy Locally

Companies with international exposure may be in for a world of hurt.